Protective effect of CV247 against cisplatin nephrotoxicity in rats

Potential Renoprotective Effects of Silymarin Against Nephrotoxic Drugs: A Review of Literature

(2016) Foroud Shahbazi et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

ACTA CLINICA BELGICA: SAME GOALS, NEW MEANS

(2014) N Lameire et al.   ACTA CLINICA BELGICA

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)

(2012) C Boni et al.   BRITISH JOURNAL OF CANCER

Lipid Peroxidative Damage on Cisplatin Exposure and Alterations in Antioxidant Defense System in Rat Kidneys: A Possible Protective Effect of Selenium

(2012) Branka I. Ognjanović et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

(2012) Antonio Rossi et al.   JOURNAL OF CLINICAL ONCOLOGY

Renal protective effect of chronic inhibition of COX-2 with SC-58236 in streptozotocin-diabetic rats

(2011) J. Quilley et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Abrogation of cisplatin-induced nephrotoxicity in mice by alpha lipoic acid through ameliorating oxidative stress and enhancing gene expression of antioxidant enzymes

(2011) Hesham A. El-Beshbishy et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents

(2010) Atsushi Yonezawa et al.   BIOCHEMICAL PHARMACOLOGY

Protecting Cisplatin-Induced Nephrotoxicity with Cimetidine Does Not Affect Antitumor Activity

(2010) Hiromu Katsuda et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients

(2010) C. Mathe et al.   EUROPEAN RESPIRATORY JOURNAL

Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature

(2010) Jeremy Setton et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Nephrotoxicity From Chemotherapeutic Agents: Clinical Manifestations, Pathobiology, and Prevention/Therapy

(2010) Mark A. Perazella et al.   SEMINARS IN NEPHROLOGY

Mechanisms of Cisplatin Nephrotoxicity

(2010) Ronald P. Miller et al.   Toxins

Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity

(2009) K K Filipski et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

(2008) Vincent Launay-Vacher et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity

(2008) Yolanda I. Chirino et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

(2008) N. Pabla et al.   KIDNEY INTERNATIONAL

Protective Effects of Vitamin C on Cisplatin-Induced Renal Damage: A Light and Electron Microscopic Study

(2008) Yeter Topcu Tarladacalisir et al.   RENAL FAILURE

Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials

(2007) Anand Rajeswaran et al.   LUNG CANCER